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Introduction {#sec001}
============

Over the last decades, many risk factors have been independently associated with cardiovascular diseases (CVD) through prospective observational studies \[[@pone.0162386.ref001], [@pone.0162386.ref002]\]. This includes behavioural risk factors (smoking \[[@pone.0162386.ref003]\], alcohol consumption \[[@pone.0162386.ref004]\] or physical inactivity \[[@pone.0162386.ref005]\]), biological characteristics (gender \[[@pone.0162386.ref006]\], age \[[@pone.0162386.ref007]\] or familial history of CVD \[[@pone.0162386.ref008]\]), clinical traits reflecting the progression of CVD (hypertension \[[@pone.0162386.ref009]\], dyslipidemia \[[@pone.0162386.ref010]\], obesity \[[@pone.0162386.ref011]\] or diabetes \[[@pone.0162386.ref012]\]), psychological factors (job strain \[[@pone.0162386.ref013]\], sleep disorders \[[@pone.0162386.ref014], [@pone.0162386.ref015]\] or depression \[[@pone.0162386.ref016]\]), and more recently biochemical markers \[[@pone.0162386.ref017]\] and genetic polymorphisms \[[@pone.0162386.ref018]\].

Despite the recognition that these factors do not act separately but jointly to determine CVD risk \[[@pone.0162386.ref019]\] and the fact that several of them have been combined in various ways to calculate scores aimed to predict the overall risk \[[@pone.0162386.ref020]\], most often they have been studied individually at different times or in different cohorts, the other factors being used mainly for statistical adjustment purposes. This makes difficult to compare the relative effect of each factor and it does not facilitate the appraisal of the network of interactions between CVD risk factors \[[@pone.0162386.ref021]\]. Two notable exceptions are the INTERHEART \[[@pone.0162386.ref022]\] and INTERSTROKE \[[@pone.0162386.ref023]\] studies which have simultaneously assessed a significant number of CVD risk factors with a transversal case-control approach. These studies have provided insights about nine or ten factors independently associated with the risk of coronary heart disease or stroke and accounting altogether for the quasi-totality of the overall risk. However, even in these two studies, the relationships between the risk factors themselves were not specifically assessed. This is also the case of a recently published study which has performed a systematic comparison of the predictors of CVD mortality in the UK Biobank population during a 5-year period \[[@pone.0162386.ref024]\].

The interest of taking into account the relationships between the risk factors is potentially high, not so much for the identification of individuals with an increased CVD risk that is usually quite good \[[@pone.0162386.ref025]\] but for improving the efficiency of preventive strategies aiming to lower this risk which are notoriously ineffective \[[@pone.0162386.ref026], [@pone.0162386.ref027]\]. Among the multiple reasons for this ineffectiveness, the failure of sufficiently considering the relationships between the risk factors may be an important one. Indeed, the simultaneous presence of several factors can lead to partial or contradictory interventions if these factors reinforce themselves by interacting with each other.

As a first step to take into account this interaction network, the present study aims to provide a global view of all the prospective relationships between the main behavioural and clinical CVD risk factors in a single cohort followed over a 20-year period.

Methods {#sec002}
=======

Study population {#sec003}
----------------

The analyses were performed in a cohort of middle-aged volunteers working at the French National Gas and Electricity Company, who were all recruited in 1989 and followed since then (GAZEL cohort) \[[@pone.0162386.ref028]\]. The recruitment took place after an information campaign inviting all men and women aged 35--50 years to participate in the cohort on a voluntary basis. The workers who volunteered (n = 20,625) were mainly white individuals of European ancestry and lived throughout the French metropolitan territory in various settings ranging from rural areas to urban centres, they have been shown to be very diverse in terms of their social, economic and occupational status, health and health-related behaviours \[[@pone.0162386.ref029]\]. They were very motivated to participate in the cohort study as indicated by the high acceptance rate at the time of the recruitment (45%) and the very low attrition rate during follow-up (\~ 3%). The response rate to a self-administered annual questionnaire also remained high during the entire follow-up (around 75%) with only less than 5% of the initial cohort who never sent back any questionnaire. All the volunteers sent written informed consent to participate to the study which has received approval from the Ethics Evaluation Committee of the Institut National de la Santé et de la Recherche Médicale and the National Committee for the Protection of Privacy and Civil Liberties (IRB0000388, FWA00005831).

Assessment of risk factors and CVD events {#sec004}
-----------------------------------------

All the data were obtained from self-administered questionnaires, completed annually by volunteers during follow-up, which contained a variety of inquiries into their lifestyle and the occurrence of health events. Among the risk factors that were considered in the analyses, gender and age were reported as such. Parental history of CVD referred to the occurrence of coronary heart disease before the age of 60 in the mother or the father. The inquiry into the occurrence of hypertension, dyslipidemia, diabetes, sleep disorder and nonfatal CVD events (which included angina pectoris, myocardial infarction, stroke and arteritis of lower limbs) was composed of two consecutive questions: first, "in the list below, indicate the diseases you are suffering or have suffered from during the past twelve months" and secondly, "among the diseases you have cited, what are the new ones, i.e., those you were not suffering from over a year ago"? Body mass index was calculated from weight and height values drawn from the questionnaires. Depressive status was assessed with the Centre of Epidemiologic Studies Depression scale and defined as scores ≥ 17 in men and ≥ 23 in women, which includes both moderate and severe depression \[[@pone.0162386.ref030]\]. The inquiry into alcohol consumption and smoking referred to the habits during the week before completing the questionnaires and was designed to take into account the culture of French people who consume alcohol on a regular basis \[[@pone.0162386.ref031]\]. Physical activity was defined by the practice of a sport whatever its frequency (occasionally, regularly or competition) as opposed to physical inactivity (no sport practice).

As the validity of self-reporting for assessing the incidence of risk factors and CVD events is always questionable, a quality control study has been performed in the GAZEL cohort by comparing CVD disorders that were reported in the questionnaire in 1992 with physician's diagnoses obtained from the sick-leave database of the company \[[@pone.0162386.ref032]\]. It shows that the issue is not over-reporting but under-reporting with a rate depending on the disorder, the characteristics of the individuals and the methodology used. Thus, under-reporting rate varies substantially from one CVD disorder to another (95.2% for diabetes, 80.4% for hypertension, 77.8% for arteritis of lower limbs, 72.4% for myocardial infarction, 71.4% for angina pectoris, 54.5% for stroke).

Statistical analyses {#sec005}
--------------------

Twelve clinical or behavioural factors were used to predict the risk of CVD events during follow-up. The rationale behind this choice was that these traditional risk factors are commonly used by physicians in their daily practice where the prevention may take place and they are likely to be available in cohorts in which the present analyses could be reproduced. Gender, parental cardiovascular disease, physical activity, hypertension, dyslipidemia, diabetes, sleep disorder and depression were coded as binary variables (women/men for gender, no/yes for the others). Age (range 39--54 years) was divided into tertiles and body mass index (BMI) into the usual 3 categories: optimal (BMI \< 25 kg/m^2^), overweight (25 kg/m^2^ ≤ BMI \< 30 kg/m^2^) or obese (BMI ≥ 30 kg/m^2^). Smoking was classified into 3 groups (non-smoker, ex-smoker, smoker) and alcohol consumption into 4 patterns using a slightly modified version of the World Health Organisation classification to take into account the distribution of the consumption in the French population: non-drinker, light drinker (1--13 drinks/week in men, 1--6 drinks/week in women), moderate drinker (14--27 drinks/week in men, 7--20 drinks/week in women) or heavy drinker (≥ 28 drinks/week in men, ≥ 21 drinks/week in women). Except for gender, age and parental CVD, the incidence of each factor during follow-up was also considered as an outcome that can be predicted by the other factors at baseline. In this case, physical inactivity, hypertension, dyslipidemia, diabetes, sleep disorder and depression were used as such. Body mass index, smoking and alcohol consumption were transformed into binary variables as follows: obese versus optimal/overweight, smoker versus non-smoker/ex-smoker and non-moderate drinker (non-drinker/light drinker/heavy drinker) versus moderate drinker.

Cox proportional hazard regression models (unadjusted, adjusted for gender and age, and multi-adjusted for the 12 risk factors (except the one being tested)) were used to compute hazard ratios and 95% confidence intervals for incident CVD events and for the incidence of each risk factor during a 20-year follow-up running from 1993 to 2013. The baseline year was 1993 because it was the first year in which all the risk factors were simultaneously assessed. Time to event was measured from baseline to the first occurrence of CVD events or the first detection of the risk factors as provided by the annual questionnaires. For each factor, the time-dependent number of volunteers at risk analysed in the corresponding Cox regression is shown in **[S1 Fig](#pone.0162386.s001){ref-type="supplementary-material"}.** The proportionality of hazards was verified by using stratified Kaplan-Meier curves which show graphically (curves roughly parallel after log(-log(survival)) versus log(time) transformation) that the assumption holds for the 47 significant associations reported in the results (**[S2 Fig](#pone.0162386.s002){ref-type="supplementary-material"}**). Note that the assumption was not verified for the 52 non-significant associations as the identification of those violating the assumption would not allow to include them in the network of significant associations but only to suspect them to be false negatives. Despite the fact that annual questionnaires produced interval censored data in the unit of one year, standard Cox regressions were used in place of proportional hazard regressions for interval censored data because it was assumed that the failure to report incident CVD events or risk factors or the delay with which they are reported in the following questionnaires do not greatly modify the estimation of hazard ratios as there is no evidence in the GAZEL cohort that the failure frequency or delay length vary to a large extent between the volunteers exposed and those not exposed to the risk factors.

Censored events include all deaths (n = 707) among which some were of cardiovascular origin (n = 112). This certainly leads to an underestimation of the magnitude of the associations with nonfatal CVD events as fatal and nonfatal events are supposed to have the same risk factors. However, this underestimation remains minimal given that the proportion of fatal events in comparison to non-fatal events is very low (7.8%). The reason of this choice is that the cause of death was not sufficiently documented to allow an accurate assessment of fatal events. Note that when analysing the incidence of risk factors, volunteers who have had a nonfatal CVD event before the first detection of the factors were also censored. Although the mortality rate is relatively low (6.6% over follow-up, see **[S3 Fig](#pone.0162386.s003){ref-type="supplementary-material"}**), it is not negligible when compared to the incident rates of CVD events or of the risk factors, especially towards the end of the follow-up. Censoring deaths as the events of interest might therefore bias the observed associations to some extent. Nevertheless, Cox regressions were used in place of competing risk models for two reasons. The first one is that the main purpose of the study is to explore the presence or absence of relationships between the risk factors rather than to determine accurately their incidence. It has been shown that censoring competing events is acceptable in this case as the HRs are relatively similar in standard Cox regressions and competing risk methods \[[@pone.0162386.ref033]\]. The second reason is that, in the present study, all the risk factors that predict the appearance of CVD events or of the other risk factors also predict death. Thus, a potential bias would likely be an under-estimation and not an over-estimation of the HRs, thereby reducing the risk of creating false positives.

The risk of CVD events was assessed in 10,736 of the 20,625 volunteers originally included in the cohort after exclusion of those who have had a nonfatal CVD event before the beginning of the follow-up period (n = 247) or those who had missing data in one or more of the risk factors included in the regression models (n = 9778). Additionally, when the outcome was the incidence of CVD risk factors during follow-up, volunteers who were exposed to the risk factors before the follow-up period or at baseline were also excluded before performing the analyses (n = 163 to 8282 depending on the factor). Note that as volunteers lost to follow-up were among those who were excluded due to missing values, all the volunteers included in the analyses were followed over the whole period of 20 years except when they died during this time period. These analyses can therefore be seen as a retrospective study conditional on the follow-up period or death within this period. Although the number of volunteers lost to follow-up is very low (n = 619), a sensitivity analysis was made to test whether the exclusion of these volunteers may bias the results of the analyses. For this purpose, multi-adjusted Cox regressions including volunteers lost to follow-up were performed with a follow-up running up to the date of the last available questionnaire (**[S1 Table](#pone.0162386.s005){ref-type="supplementary-material"}**). The comparison with multi-adjusted Cox regressions excluding these volunteers with the 20-year follow-up indicates that the bias is very small as all the associations with incident CVD events and the vast majority of those with incident risk factors are conserved (one new association and none lost out of 47 at p\<0.05, one new association and 3 lost out of 22 at p\<0.0001).

The choice of using only volunteers with a complete set of data was made by considering that a multiple imputation approach in a cohort where the distribution of missing values is not monotonous (see the overall pattern of missing data for the 12 risk factors included in the analyses in **[S4 Fig](#pone.0162386.s004){ref-type="supplementary-material"}**) would require to use multivariate imputation by chained equations which is time-consuming and not always devoid of biases \[[@pone.0162386.ref034], [@pone.0162386.ref035]\]. Of course, the exclusion of a large number of volunteers with missing data leads to the selection of a significantly healthier population. As shown in **[S2 Table](#pone.0162386.s006){ref-type="supplementary-material"}**, the rates of hypertension, dyslipidemia, diabetes and depression, as well as those of smoking and physical inactivity, are significantly lower in the selected volunteers. To test to which extent this selection may affect the results presented in this study, two types of sensitivity analyses were performed. The first one was to run Cox regressions weighted by the inverse probability of being selected; this probability was calculated by using a multivariate logistic regression model including five risk factors, averaged over the 4-year period (1989--1992) preceding the baseline year in order to minimize the number of missing values, which were significantly associated with the selection (OR (95%CI): gender W/M 0.78 (0.71--0.87), hypertension Y/N 0.84 (0.75--0.94), dyslipidemia Y/N 0.81 (0.68--0.98), depression Y/N 0.71 (0.64--0.78) and smoking Y/N 0.77 (0.71--0.84). The comparison of the outputs of weighted (**[S3 Table](#pone.0162386.s007){ref-type="supplementary-material"}**) and unweighted multi-adjusted Cox regressions shows that all the associations with incident CVD events and most of those with incident risk factors are conserved (9 new associations and 3 lost out of 47 at p\<0.05, 3 new associations and 2 lost out of 22 at p\<0.0001). The second sensitivity analysis consisted of comparing the outputs of gender-age adjusted Cox regressions in volunteers with complete data either for all the risk factors (i.e., the population selected for the study) or only for the factor analysed in each model (given that gender and age were available for all volunteers); the number of volunteers excluded is large in the first case while it is much smaller and varies from one model to another depending on the risk factor in the second case. **[S4 Table](#pone.0162386.s008){ref-type="supplementary-material"}** shows that all the associations with incident CVD events and most of those with incident risk factors are conserved (12 new associations and none lost out of 61 at p\<0.05, 10 new associations and 2 lost out of 36 at p\<0.0001); note that the number of gender-age adjusted associations in volunteers with complete data in all the risk factors is greater than the number reported in the Results where only the associations observed in multi-adjusted models are shown. In both sensitivity analyses, it appears that the variations in the HRs (95% CI) explaining the shift of some associations above or below statistical thresholds are small in the vast majority of the cases.

Several risk factors such as hypertension, dyslipidemia or diabetes have a tendency to be irreversible once declared but others such as behavioural factors can potentially vary significantly throughout the 20-year follow-up. Multi-adjusted Cox regressions with time-dependent predictive risk factors (tested as binary covariates) were therefore performed to estimate the bias that may be introduced by considering these factors as time-independent. As shown in **[S5 Table](#pone.0162386.s009){ref-type="supplementary-material"}**, although the magnitude of some HRs can vary substantially (in the case of the associations with depression for example), all but one (physical inactivity) of the associations with incident CVD events and most of those with incident risk factors are conserved (3 new associations and 3 lost out of 47 at p\<0.05, one new association and 4 lost out of 22 at p\<0.0001). Most importantly, this does not modify the conceptual framework summarizing the main findings of the study ([Fig 1](#pone.0162386.g001){ref-type="fig"}) whether it is based on the associations at p\<0.05 or on those at p\<0.0001. Consequently, predictive risk factors have been considered as time-independent in the regression models presented in the Results for the sake of simplicity.

![Conceptual framework of the relationships between CVD risk factors.\
The factors are grouped into 4 types based on the number of other factors predicting each of them. The numbers next to the arrows represent the number of prospective associations between or within the 4 types of factors at p\<0.05 or p\<0.0001 (in parenthesis).](pone.0162386.g001){#pone.0162386.g001}

An issue related to multiple testing is the risk of having false positives which increases with the number of tests performed (n = 17 × 9 × 3 in the present case). To take this problem into account, a Bonferroni correction could be applied in order to keep only the tests with p\<0.0001 (0.05/(17 × 9 × 3)). However, this correction comes at the cost of increasing the probability of having false negatives, which would be clearly the case in this study where several well-known dose-dependent associations are observed at 0.0001\<p\<0.05. Thus, rather than choosing between keeping potential false positives or excluding potential false negatives, we decided to show all the associations with p\<0.05 leaving open the possibility of narrowing the significance threshold to 0.01, 0.001 or 0.0001, depending on the priority of the reader. In fact, this issue is not critical as the main conclusions that can be drawn from the analyses, i.e., the existence of an extensive network of relationships between the main CVD risk factors, its conceptual framework and its potential interest in prevention, are fundamentally the same whatever the significance threshold which is selected.

All analyses were performed with the statistical discovery software JMP Pro 12 (SAS, Cary NC).

Results {#sec006}
=======

Associations of the risk factors at baseline with the incidence of CVD events {#sec007}
-----------------------------------------------------------------------------

Among the 10,736 volunteers retained for the analyses, whose baseline characteristics are shown in **[Table 1](#pone.0162386.t001){ref-type="table"}**, a total of 1694 nonfatal CVD events occurred during follow-up (mean/median 11.4/12.0 years for volunteers with event, 19.7/20.0 years for volunteers without event) corresponding to 7.9 events per 1000 person-years. The distribution of these events according to the risk factors at baseline is shown in **[Table 2](#pone.0162386.t002){ref-type="table"}**with the hazard ratios. All the factors independently predict CVD risk with multi-adjusted HRs varying from 1.18 to 1.97.

10.1371/journal.pone.0162386.t001

###### Baseline distribution of clinical or behavioural predictive factors among the 10736 volunteers retained to assess CVD risk.

![](pone.0162386.t001){#pone.0162386.t001g}

                            N (%)         
  ------------------------- ------------- --------------
  **Gender**                Women         2723 (25.4)
  Men                       8013 (74.6)   
  **Age (y)**               39--45        3542 (33.0)
  46--49                    3547 (33.0)   
  50--54                    3647 (34.0)   
  **Parental CVD**          No            9437 (87.9)
  Yes                       1299 (12.1)   
  **Alcohol consumption**   Non-drinker   1277 (11.9)
  Light drinker             5659 (52.7)   
  Moderate drinker          2454 (22.9)   
  Heavy drinker             1346 (12.5)   
  **Smoking**               Non-smoker    4694 (43.7)
  Ex-smoker                 4035 (37.6)   
  Smoker                    2007 (18.7)   
  **Physical activity**     No            3365 (31.3)
  Yes                       7371 (68.7)   
  **Body mass index**       Optimal       5762 (53.7)
  Overweight                4328 (40.3)   
  Obesity                   646 (6.0)     
  **Hypertension**          No            9717 (90.5)
  Yes                       1019 (9.5)    
  **Dyslipidemia**          No            9030 (84.1)
  Yes                       1706 (15.9)   
  **Diabetes**              No            10573 (98.5)
  Yes                       163 (1.5)     
  **Sleep disorder**        No            7937 (73.9)
  Yes                       2799 (26.1)   
  **Depression**            No            8314 (77.4)
  Yes                       2422 (22.6)   

10.1371/journal.pone.0162386.t002

###### Risk of CVD events according to predictive factors at baseline.
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                            No. of cases   Unadjusted          Gender & age-adjusted   Multi-adjusted                                                
  ------------------------- -------------- ------------------- ----------------------- ------------------- ---------- ------------------- ---------- --
  **Diabetes**              No             1638                1.00                                        1.00                           1.00       
  Yes                       56             2.65 (2.01--3.43)   \<0.0001                2.36 (1.79--3.05)   \<0.0001   1.97 (1.49--2.56)   \<0.0001   
  **Gender**                Women          236                 1.00                                        1.00                           1.00       
  Men                       1458           2.21 (1.93--2.54)   \<0.0001                1.98 (1.72--2.28)   \<0.0001   1.87 (1.61--2.18)   \<0.0001   
  **Smoking**               Non-smoker     553                 1.00                                        1.00                           1.00       
  Ex-smoker                 710            1.56 (1.39--1.74)   \<0.0001                1.34 (1.20--1.50)   \<0.0001   1.28 (1.14--1.44)   \<0.0001   
  Smoker                    431            2.02 (1.78--2.29)   \<0.0001                1.84 (1.62--2.09)   \<0.0001   1.81 (1.59--2.06)   \<0.0001   
  **Age (y)**               39--45         559                 1.00                                        1.00                           1.00       
  46--49                    559            1.51 (1.33--1.72)   \<0.0001                1.30 (1.14--1.48)   \<0.0001   1.26 (1.10--1.44)   0.0006     
  50--54                    576            1.93 (1.71--2.19)   \<0.0001                1.67 (1.47--1.89)   \<0.0001   1.58 (1.40--1.80)   \<0.0001   
  **Hypertension**          No             1437                1.00                                        1.00                           1.00       
  Yes                       257            1.87 (1.63--2.13)   \<0.0001                1.77 (1.55--2.02)   \<0.0001   1.52 (1.32--1.74)   \<0.0001   
  **Body mass index**       Optimal        748                 1.00                                        1.00                           1.00       
  Overweight                779            1.43 (1.29--1.58)   \<0.0001                1.20 (1.08--1.33)   0.0007     1.09 (0.98--1.21)   0.10       
  Obesity                   167            2.18 (1.83--2.57)   \<0.0001                1.90 (1.60--2.25)   \<0.0001   1.47 (1.23--1.75)   \<0.0001   
  **Parental CVD**          No             1417                1.00                                        1.00                           1.00       
  Yes                       277            1.47 (1.29--1.67)   \<0.0001                1.52 (1.34--1.73)   \<0.0001   1.45 (1.28--1.65)   \<0.0001   
  **Alcohol consumption**   Non-drinker    197                 1.00                                        1.00                           1.00       
  Light drinker             879            0.98 (0.85--1.15)   0.84                    0.83 (0.71--0.97)   0.02       0.86 (0.74--1.01)   0.06       
  Moderate drinker          358            0.93 (0.78--1.10)   0.39                    0.75 (0.63--0.90)   0.002      0.75 (0.63--0.90)   0.002      
  Heavy drinker             260            1.30 (1.08--1.56)   0.006                   0.97 (0.80--1.17)   0.73       0.85 (0.70--1.03)   0.10       
  **Sleep disorder**        No             1189                1.00                                        1.00                           1.00       
  Yes                       505            1.23 (1.11--1.36)   0.0001                  1.34 (1.21--1.49)   \<0.0001   1.26 (1.13--1.40)   \<0.0001   
  **Dyslipidemia**          No             1320                1.00                                        1.00                           1.00       
  Yes                       374            1.60 (1.43--1.79)   \<0.0001                1.42 (1.26--1.59)   \<0.0001   1.24 (1.10--1.39)   0.0004     
  **Physical activity**     No             623                 1.00                                        1.00                           1.00       
  Yes                       1071           0.75 (0.68--0.83)   \<0.0001                0.72 (0.66--0.80)   \<0.0001   0.81 (0.73--0.90)   \<0.0001   
  **Depression**            No             1237                1.00                                        1.00                           1.00       
  Yes                       457            1.32 (1.18--1.47)   \<0.0001                1.34 (1.20--1.49)   \<0.0001   1.18 (1.06--1.32)   0.004      

Associations between the risk factors at baseline and their incidence during follow-up {#sec008}
--------------------------------------------------------------------------------------

Only one risk factor independently predicts the incidence of non-moderate alcohol consumption (2477 cases among 2691 volunteers during follow-up (mean/median 2.9/1.0 years for volunteers with incident cases, 18.2/20.0 years for volunteers without incident cases) or 46.0 cases per 1000 person-years) with multi-adjusted HRs ranging from 1.13 to 1.14 (**[Table 3](#pone.0162386.t003){ref-type="table"})**.

10.1371/journal.pone.0162386.t003

###### Risk of non-moderate alcohol consumption according to predictive factors at baseline.
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                No. of cases   Unadjusted          Gender & age-adjusted   Multi-adjusted                                        
  ------------- -------------- ------------------- ----------------------- ------------------- ------ ------------------- ------ --
  **Smoking**   Non-smoker     933                 1.00                                        1.00                       1.00   
  Ex-smoker     991            1.16 (1.06--1.26)   0.001                   1.12 (1.02--1.23)   0.01   1.13 (1.03--1.24)   0.01   
  Smoker        553            1.17 (1.05--1.30)   0.004                   1.14 (1.02--1.27)   0.02   1.14 (1.02--1.27)   0.02   

Only predictive factors significantly associated with incident non-moderate alcohol consumption in the multi-adjusted model are shown in the table.

The incidence of smoking (1041 cases among 8092 volunteers during follow-up (mean/median 8.3/7.0 years for volunteers with incident cases, 19.9/20.0 years for volunteers without incident cases) or 6.4 cases per 1000 person-years) is independently predicted by two factors with multi-adjusted HRs varying from 1.18 to 1.29 (**[Table 4](#pone.0162386.t004){ref-type="table"}**).

10.1371/journal.pone.0162386.t004

###### Risk of smoking according to predictive factors at baseline.
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                        No. of cases   Unadjusted          Gender & age-adjusted   Multi-adjusted                                            
  --------------------- -------------- ------------------- ----------------------- ------------------- -------- ------------------- -------- --
  **Body mass index**   Optimal        508                 1.00                                        1.00                         1.00     
  Overweight            466            1.29 (1.13--1.46)   \<0.0001                1.29 (1.13--1.48)   0.0001   1.29 (1.12--1.47)   0.0002   
  Obesity               67             1.25 (0.96--1.60)   0.09                    1.26 (0.97--1.62)   0.08     1.27 (0.97--1.64)   0.08     
  **Depression**        No             786                 1.00                                        1.00                         1.00     
  Yes                   255            1.19 (1.03--1.37)   0.02                    1.19 (1.03--1.37)   0.02     1.18 (1.02--1.37)   0.02     

Only predictive factors significantly associated with incident smoking in the multi-adjusted model are shown in the table.

Six factors independently predict the incidence of physical inactivity (3325 cases among 7371 volunteers during follow-up (mean/median 8.7/9.0 years for volunteers with incident cases, 19.2/20.0 years for volunteers without incident cases) or 22.6 cases per 1000 person-years) with multi-adjusted HRs ranging from 1.14 to 1.73 (**[Table 5](#pone.0162386.t005){ref-type="table"}**).

10.1371/journal.pone.0162386.t005

###### Risk of physical inactivity according to predictive factors at baseline.
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                        No. of cases   Unadjusted          Gender & age-adjusted   Multi-adjusted                                                
  --------------------- -------------- ------------------- ----------------------- ------------------- ---------- ------------------- ---------- --
  **Body mass index**   Optimal        1722                1.00                                        1.00                           1.00       
  Overweight            1388           1.19 (1.11--1.28)   \<0.0001                1.24 (1.15--1.34)   \<0.0001   1.22 (1.13--1.32)   \<0.0001   
  Obesity               215            1.76 (1.52--2.02)   \<0.0001                1.80 (1.56--2.08)   \<0.0001   1.73 (1.49--2.00)   \<0.0001   
  **Smoking**           Non-smoker     1382                1.00                                        1.00                           1.00       
  Ex-smoker             1237           1.03 (0.96--1.11)   0.42                    1.05 (0.97--1.13)   0.24       1.00 (0.92--1.08)   0.93       
  Smoker                706            1.40 (1.28--1.53)   \<0.0001                1.41 (1.29--1.55)   \<0.0001   1.37 (1.25--1.50)   \<0.0001   
  **Depression**        No             2561                1.00                                        1.00                           1.00       
  Yes                   764            1.21 (1.11--1.31)   \<0.0001                1.21 (1.11--1.31)   \<0.0001   1.17 (1.07--1.27)   0.0003     
  **Dyslipidemia**      No             2758                1.00                                        1.00                           1.00       
  Yes                   567            1.22 (1.11--1.33)   \<0.0001                1.24 (1.13--1.36)   \<0.0001   1.17 (1.06--1.28)   0.001      
  **Gender**            Women          773                 1.00                                        1.00                           1.00       
  Men                   2552           0.96 (0.88--1.04)   0.30                    0.97 (0.89--1.05)   0.42       0.87 (0.79--0.95)   0.003      
  **Hypertension**      No             3016                1.00                                        1.00                           1.00       
  Yes                   309            1.23 (1.10--1.39)   0.0006                  1.24 (1.10--1.40)   0.0004     1.14 (1.01--1.28)   0.04       

Only predictive factors significantly associated with incident physical inactivity in the multi-adjusted model are shown in the table.

**[Table 6](#pone.0162386.t006){ref-type="table"}**shows that the incidence of obesity (1813 cases among 10,267 volunteers during follow-up (mean/median 8.4/8.0 years for volunteers with incident cases, 19.7/20.0 years for volunteers without incident cases) or 8.8 cases per 1000 person-years) is independently predicted by 5 factors with multi-adjusted HRs varying from 1.20 to 1.90.

10.1371/journal.pone.0162386.t006

###### Risk of obesity according to predictive factors at baseline.

![](pone.0162386.t006){#pone.0162386.t006g}

                          No. of cases   Unadjusted          Gender & age-adjusted   Multi-adjusted                                                
  ----------------------- -------------- ------------------- ----------------------- ------------------- ---------- ------------------- ---------- --
  **Hypertension**        No             1550                1.00                                        1.00                           1.00       
  Yes                     263            2.00 (1.75--2.28)   \<0.0001                2.03 (1.78--2.31)   \<0.0001   1.90 (1.66--2.16)   \<0.0001   
  **Smoking**             Non-smoker     631                 1.00                                        1.00                           1.00       
  Ex-smoker               779            1.54 (1.39--1.71)   \<0.0001                1.55 (1.39--1.73)   \<0.0001   1.53 (1.37--1.71)   \<0.0001   
  Smoker                  403            1.60 (1.41--1.81)   \<0.0001                1.60 (1.41--1.82)   \<0.0001   1.59 (1.40--1.81)   \<0.0001   
  **Physical activity**   No             703                 1.00                                        1.00                           1.00       
  Yes                     1110           0.64 (0.58--0.71)   \<0.0001                0.63 (0.57--0.69)   \<0.0001   0.67 (0.61--0.74)   \<0.0001   
  **Dyslipidemia**        No             1464                1.00                                        1.00                           1.00       
  Yes                     349            1.36 (1.21--1.53)   \<0.0001                1.37 (1.21--1.53)   \<0.0001   1.23 (1.09--1.38)   0.001      
  **Depression**          No             1333                1.00                                        1.00                           1.00       
  Yes                     480            1.28 (1.15--1.42)   \<0.0001                1.29 (1.16--1.43)   \<0.0001   1.20 (1.07--1.33)   0.001      

Only predictive factors significantly associated with incident obesity in the multi-adjusted model are shown in the table.

The incidence of hypertension (3950 cases among 9918 volunteers during follow-up (mean/median 9.9/10.0 years for volunteers with incident cases, 19.6/20.0 years for volunteers without incident cases) or 19.9 cases per 1000 person-years) is independently predicted by 8 factors with multi-adjusted HRs ranging from 1.09 to 2.78 (**[Table 7](#pone.0162386.t007){ref-type="table"}**).

10.1371/journal.pone.0162386.t007

###### Risk of hypertension according to predictive factors at baseline.

![](pone.0162386.t007){#pone.0162386.t007g}

                          No. of cases   Unadjusted          Gender & age-adjusted   Multi-adjusted                                                
  ----------------------- -------------- ------------------- ----------------------- ------------------- ---------- ------------------- ---------- --
  **Body mass index**     Optimal        1732                1.00                                        1.00                           1.00       
  Overweight              1889           1.72 (1.61--1.84)   \<0.0001                1.73 (1.62--1.86)   \<0.0001   1.69 (1.57--1.81)   \<0.0001   
  Obesity                 329            2.94 (2.61--3.31)   \<0.0001                2.94 (2.61--3.31)   \<0.0001   2.78 (2.46--3.14)   \<0.0001   
  **Age (y)**             39--45         1302                1.00                                        1.00                           1.00       
  46--49                  1307           1.23 (1.14--1.33)   \<0.0001                1.20 (1.11--1.31)   \<0.0001   1.18 (1.08--1.28)   \<0.0001   
  50--54                  1341           1.40 (1.29--1.51)   \<0.0001                1.37 (1.26--1.48)   \<0.0001   1.32 (1.21--1.42)   \<0.0001   
  **Diabetes**            No             3880                1.00                                        1.00                           1.00       
  Yes                     70             1.61 (1.26--2.02)   0.0002                  1.53 (1.20--1.93)   0.0009     1.29 (1.01--1.63)   0.04       
  **Dyslipidemia**        No             3224                1.00                                        1.00                           1.00       
  Yes                     726            1.41 (1.30--1.53)   \<0.0001                1.36 (1.25--1.48)   \<0.0001   1.27 (1.17--1.37)   \<0.0001   
  **Parental CVD**        No             3418                1.00                                        1.00                           1.00       
  Yes                     532            1.24 (1.13--1.36)   \<0.0001                1.26 (1.15--1.38)   \<0.0001   1.21 (1.10--1.33)   \<0.0001   
  **Sleep disorder**      No             2843                1.00                                        1.00                           1.00       
  Yes                     1107           1.18 (1.10--1.26)   \<0.0001                1.20 (1.12--1.29)   \<0.0001   1.16 (1.08--1.24)   \<0.0001   
  **Depression**          No             2991                1.00                                        1.00                           1.00       
  Yes                     959            1.19 (1.11--1.28)   \<0.0001                1.19 (1.11--1.28)   \<0.0001   1.14 (1.06--1.23)   0.0007     
  **Physical activity**   No             1308                1.00                                        1.00                           1.00       
  Yes                     2642           0.83 (0.78--0.89)   \<0.0001                0.83 (0.78--0.89)   \<0.0001   0.91 (0.85--0.98)   0.01       

Only predictive factors significantly associated with incident hypertension in the multi-adjusted model are shown in the table.

Nine factors independently predict the incidence of dyslipidemia (4426 cases among 9257 volunteers during follow-up (mean/median 8.1/8.0 years for volunteers with incident cases, 19.5/20.0 years for volunteers without incident cases) or 23.9 cases per 1000 person-years) with multi-adjusted HRs varying from 1.09 to 1.51 (**[Table 8](#pone.0162386.t008){ref-type="table"}**).

10.1371/journal.pone.0162386.t008

###### Risk of dyslipidemia according to predictive factors at baseline.

![](pone.0162386.t008){#pone.0162386.t008g}

                          No. of cases   Unadjusted          Gender & age-adjusted   Multi-adjusted                                                
  ----------------------- -------------- ------------------- ----------------------- ------------------- ---------- ------------------- ---------- --
  **Hypertension**        No             3921                1.00                                        1.00                           1.00       
  Yes                     505            1.66 (1.51--1.82)   \<0.0001                1.63 (1.48--1.78)   \<0.0001   1.51 (1.37--1.65)   \<0.0001   
  **Body mass index**     Optimal        2257                1.00                                        1.00                           1.00       
  Overweight              1871           1.35 (1.27--1.43)   \<0.0001                1.32 (1.24--1.41)   \<0.0001   1.27 (1.19--1.36)   \<0.0001   
  Obesity                 298            1.60 (1.42--1.81)   \<0.0001                1.57 (1.38--1.77)   \<0.0001   1.39 (1.23--1.58)   \<0.0001   
  **Diabetes**            No             4360                1.00                                        1.00                           1.00       
  Yes                     66             1.60 (1.24--2.02)   0.0004                  1.53 (1.19--1.94)   0.001      1.38 (1.07--1.75)   0.01       
  **Age (y)**             39--45         1459                1.00                                        1.00                           1.00       
  46--49                  1462           1.20 (1.11--1.29)   \<0.0001                1.17 (1.09--1.27)   \<0.0001   1.14 (1.06--1.23)   0.0006     
  50--54                  1505           1.31 (1.22--1.41)   \<0.0001                1.28 (1.19--1.38)   \<0.0001   1.22 (1.13--1.32)   \<0.0001   
  **Smoking**             Non-smoker     1896                1.00                                        1.00                           1.00       
  Ex-smoker               1657           1.16 (1.08--1.24)   \<0.0001                1.13 (1.06--1.21)   0.0004     1.08 (1.01--1.16)   0.03       
  Smoker                  873            1.22 (1.13--1.32)   \<0.0001                1.21 (1.12--1.31)   \<0.0001   1.18 (1.09--1.28)   \<0.0001   
  **Depression**          No             3345                1.00                                        1.00                           1.00       
  Yes                     1081           1.18 (1.10--1.27)   \<0.0001                1.19 (1.11--1.27)   \<0.0001   1.13 (1.05--1.21)   0.0008     
  **Sleep disorder**      No             3190                1.00                                        1.00                           1.00       
  Yes                     1236           1.13 (1.06--1.21)   0.0002                  1.16 (1.08--1.24)   \<0.0001   1.11 (1.04--1.19)   0.002      
  **Parental CVD**        No             3872                1.00                                        1.00                           1.00       
  Yes                     554            1.14 (1.04--1.24)   0.005                   1.15 (1.05--1.25)   0.003      1.10 (1.01--1.21)   0.03       
  **Physical activity**   No             1458                1.00                                        1.00                           1.00       
  Yes                     2968           0.86 (0.81--0.91)   \<0.0001                0.86 (0.80--0.91)   \<0.0001   0.91 (0.86--0.98)   0.007      

Only predictive factors significantly associated with incident dyslipidemia in the multi-adjusted model are shown in the table.

**[Table 9](#pone.0162386.t009){ref-type="table"}**shows that 7 factors independently predict the incidence of diabetes (1138 cases among 10,578 volunteers during follow-up (mean/median 10.9/11.0 years for volunteers with incident cases, 19.7/20.0 years for volunteers without incident cases) or 5.4 cases per 1000 person-years). with multi-adjusted HRs ranging from 1.15 to 6.12.

10.1371/journal.pone.0162386.t009

###### Risk of diabetes according to predictive factors at baseline.

![](pone.0162386.t009){#pone.0162386.t009g}

                          No. of cases   Unadjusted          Gender & age-adjusted   Multi-adjusted                                                
  ----------------------- -------------- ------------------- ----------------------- ------------------- ---------- ------------------- ---------- --
  **Body mass index**     Optimal        319                 1.00                                        1.00                           1.00       
  Overweight              594            2.59 (2.27--2.98)   \<0.0001                2.46 (2.13--2.84)   \<0.0001   2.23 (1.93--2.58)   \<0.0001   
  Obesity                 225            8.01 (6.75--9.50)   \<0.0001                7.69 (6.46--9.14)   \<0.0001   6.12 (5.10--7.33)   \<0.0001   
  **Hypertension**        No             910                 1.00                                        1.00                           1.00       
  Yes                     228            2.69 (2.32--3.10)   \<0.0001                2.62 (2.26--3.02)   \<0.0001   1.75 (1.50--2.04)   \<0.0001   
  **Dyslipidemia**        No             824                 1.00                                        1.00                           1.00       
  Yes                     314            2.19 (1.92--2.49)   \<0.0001                2.03 (1.78--2.32)   \<0.0001   1.66 (1.45--1.89)   \<0.0001   
  **Smoking**             Non-smoker     373                 1.00                                        1.00                           1.00       
  Ex-smoker               489            1.58 (1.38--1.81)   \<0.0001                1.44 (1.25--1.65)   \<0.0001   1.18 (1.02--1.36)   0.02       
  Smoker                  276            1.85 (1.58--2.16)   \<0.0001                1.74 (1.49--2.04)   \<0.0001   1.57 (1.34--1.84)   \<0.0001   
  **Depression**          No             823                 1.00                                        1.00                           1.00       
  Yes                     315            1.36 (1.19--1.55)   \<0.0001                1.37 (1.20--1.56)   \<0.0001   1.25 (1.09--1.43)   0.001      
  **Parental CVD**        No             964                 1.00                                        1.00                           1.00       
  Yes                     174            1.32 (1.12--1.55)   0.001                   1.35 (1.14--1.58)   0.0005     1.21 (1.02--1.42)   0.02       
  **Physical activity**   No             446                 1.00                                        1.00                           1.00       
  Yes                     692            0.67 (0.60--0.76)   \<0.0001                0.66 (0.58--0.74)   \<0.0001   0.85 (0.75--0.96)   0.01       

Only predictive factors significantly associated with incident diabetes in the multi-adjusted model are shown in the table.

The incidence of sleep disorder (5226 cases among 8815 volunteers during follow-up (mean/median 5.7/4.0 years for volunteers with incident cases, 19.7/20.0 years for volunteers without incident cases) or 29.6 cases per 1000 person-years) is independently predicted by 5 factors with multi-adjusted HRs ranging from 1.13 to 1.88 (**[Table 10](#pone.0162386.t010){ref-type="table"}**).

10.1371/journal.pone.0162386.t010

###### Risk of sleep disorder according to predictive factors at baseline.
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                     No. of cases   Unadjusted          Gender & age-adjusted   Multi-adjusted                                                
  ------------------ -------------- ------------------- ----------------------- ------------------- ---------- ------------------- ---------- --
  **Depression**     No             3949                1.00                                        1.00                           1.00       
  Yes                1277           1.86 (1.75--1.98)   \<0.0001                1.88 (1.77--2.00)   \<0.0001   1.88 (1.76--2.00)   \<0.0001   
  **Gender**         Women          1586                1.00                                        1.00                           1.00       
  Men                3640           0.57 (0.54--0.61)   \<0.0001                0.58 (0.55--0.62)   \<0.0001   0.56 (0.52--0.60)   \<0.0001   
  **Age (y)**        39--45         1723                1.00                                        1.00                           1.00       
  46--49             1726           0.90 (0.84--0.96)   0.001                   1.03 (0.96--1.10)   0.41       1.03 (0.96--1.10)   0.43       
  50--54             1777           0.78 (0.73--0.83)   \<0.0001                0.89 (0.83--0.95)   0.0009     0.88 (0.82--0.94)   0.0002     
  **Parental CVD**   No             4554                1.00                                        1.00                           1.00       
  Yes                672            1.17 (1.08--1.27)   0.0002                  1.15 (1.06--1.25)   0.0008     1.14 (1.05--1.24)   0.002      
  **Smoking**        Non-smoker     2361                1.00                                        1.00                           1.00       
  Ex-smoker          1886           0.92 (0.86--0.97)   0.005                   1.06 (0.99--1.13)   0.08       1.04 (0.97--1.11)   0.25       
  Smoker             979            1.04 (0.97--1.12)   0.29                    1.15 (1.07--1.24)   0.0003     1.13 (1.05--1.22)   0.002      

Only predictive factors significantly associated with incident sleep disorder in the multi-adjusted model are shown in the table.

Four factors independently predict the incidence of depression (2519 cases among 8314 volunteers during follow-up (mean/median 6.8/6.0 years for volunteers with incident cases, 19.8/20.0 years for volunteers without incident cases) or 15.1 cases per 1000 person-years) with multi-adjusted HRs varying from 1.11 to 1.78 (**[Table 11](#pone.0162386.t011){ref-type="table"}**).

10.1371/journal.pone.0162386.t011

###### Risk of depression according to predictive factors at baseline.

![](pone.0162386.t011){#pone.0162386.t011g}

                       No. of cases   Unadjusted          Gender & age-adjusted   Multi-adjusted                                                
  -------------------- -------------- ------------------- ----------------------- ------------------- ---------- ------------------- ---------- --
  **Sleep disorder**   No             1778                1.00                                        1.00                           1.00       
  Yes                  741            1.80 (1.65--1.96)   \<0.0001                1.78 (1.63--1.94)   \<0.0001   1.77 (1.62--1.93)   \<0.0001   
  **Age (y)**          39--45         831                 1.00                                        1.00                           1.00       
  46--49               832            0.91 (0.83--0.99)   0.04                    0.93 (0.85--1.03)   0.16       0.92 (0.83--1.01)   0.08       
  50--54               856            0.77 (0.70--0.84)   \<0.0001                0.79 (0.71--0.87)   \<0.0001   0.78 (0.70--0.86)   \<0.0001   
  **Smoking**          Non-smoker     1081                1.00                                        1.00                           1.00       
  Ex-smoker            918            1.01 (0.92--1.10)   0.87                    1.06 (0.96--1.16)   0.23       1.02 (0.93--1.12)   0.62       
  Smoker               520            1.22 (1.10--1.35)   0.0002                  1.25 (1.13--1.39)   \<0.0001   1.22 (1.10--1.36)   0.0003     
  **Parental CVD**     No             2175                1.00                                        1.00                           1.00       
  Yes                  344            1.18 (1.06--1.33)   0.004                   1.17 (1.05--1.31)   0.007      1.14 (1.01--1.27)   0.03       

Only predictive factors significantly associated with incident depression in the multi-adjusted model are shown in the table.

Overview of the associations between the risk factors {#sec009}
-----------------------------------------------------

**[Table 12](#pone.0162386.t012){ref-type="table"}**summarizes multi-adjusted HRs for all the associations that have been observed between the risk factors. The number of associations is 47 at p\<0.05, 37 at p\<0.01, 28 at p\<0.001 and 22 at p\<0.0001. The number of factors associated with a given factor varies from 1 to 9 at p\<0.05 (from 0 to 6 at p\<0.0001) with a number of predictive or predicted factors ranging respectively from 0 to 9 and from 0 to 7 at p\<0.05 (from 0 to 5 and from 0 to 4 at p\<0.0001) as reported in **[Table 13](#pone.0162386.t013){ref-type="table"}**.

10.1371/journal.pone.0162386.t012

###### Risk of incident CVD factors according to the same factors at baseline---summary of multi-adjusted associations.
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  Predictive factors        Incident factors                                                                                                                                                       
  ------------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------------------- ------ ------
  **Diabetes**              No                  \-                  NS                  1.00                NS                  NS                  NS                  1.00                NS     NS
  Yes                       1.29 (1.01--1.63)   1.38 (1.07--1.75)                                                                                                                                  
  **Gender**                Women               NS                  NS                  NS                  NS                  NS                  1.00                NS                  1.00   NS
  Men                       0.56 (0.52--0.60)   0.87 (0.79--0.95)                                                                                                                                  
  **Smoking**               Non-smoker          1.00                                    NS                  1.00                1.00                1.00                1.00                1.00   1.00
  Ex-smoker                 1.18 (1.02--1.36)   \-                  1.53 (1.37--1.71)   1.13 (1.03--1.24)   1.04 (0.97--1.11)   1.08 (1.01--1.16)   1.00 (0.92--1.08)   1.02 (0.93--1.12)          
  Smoker                    1.57 (1.34--1.84)                       1.59 (1.40--1.81)   1.14 (1.02--1.27)   1.13 (1.05--1.22)   1.18 (1.09--1.28)   1.37 (1.25--1.50)   1.22 (1.10--1.36)          
  **Age (y)**               39--45              NS                  NS                  1.00                NS                  NS                  1.00                1.00                NS     1.00
  46--49                    1.18 (1.08--1.28)   1.03 (0.96--1.10)   1.14 (1.06--1.23)   0.92 (0.83--1.01)                                                                                          
  50--54                    1.32 (1.21--1.42)   0.88 (0.82--0.94)   1.22 (1.13--1.32)   0.78 (0.70--0.86)                                                                                          
  **Hypertension**          No                  1.00                NS                  \-                  1.00                NS                  NS                  1.00                1.00   NS
  Yes                       1.75 (1.50--2.04)   1.90 (1.66--2.16)   1.51 (1.37--1.65)   1.14 (1.01--1.28)                                                                                          
  **Body mass index**       Optimal             1.00                1.00                1.00                                    NS                  NS                  1.00                1.00   NS
  Overweight                2.23 (1.93--2.58)   1.29 (1.12--1.47)   1.69 (1.57--1.81)   \-                  1.27 (1.19--1.36)   1.22 (1.13--1.32)                                                  
  Obesity                   6.12 (5.10--7.33)   1.27 (0.97--1.64)   2.78 (2.46--3.14)                       1.39 (1.23--1.58)   1.73 (1.49--2.00)                                                  
  **Parental CVD**          No                  1.00                NS                  1.00                NS                  NS                  1.00                1.00                NS     1.00
  Yes                       1.21 (1.02--1.42)   1.21 (1.10--1.33)   1.14 (1.05--1.24)   1.10 (1.01--1.21)   1.14 (1.01--1.27)                                                                      
  **Alcohol consumption**   Non-drinker         NS                  NS                  NS                  NS                  \-                  NS                  NS                  NS     NS
  Light drinker                                                                                                                                                                                    
  Moderate drinker                                                                                                                                                                                 
  Heavy drinker                                                                                                                                                                                    
  **Sleep disorder**        No                  NS                  NS                  1.00                NS                  NS                  \-                  1.00                NS     1.00
  Yes                       1.16 (1.08--1.24)   1.11 (1.04--1.19)   1.77 (1.62--1.93)                                                                                                              
  **Dyslipidemia**          No                  1.00                NS                  1.00                1.00                NS                  NS                  \-                  1.00   NS
  Yes                       1.66 (1.45--1.89)   1.27 (1.17--1.37)   1.23 (1.09--1.38)   1.17 (1.06--1.28)                                                                                          
  **Physical activity**     No                  1.00                NS                  1.00                1.00                NS                  NS                  1.00                \-     NS
  Yes                       0.85 (0.75--0.96)   0.91 (0.85--0.98)   0.67 (0.61--0.74)   0.91 (0.86--0.98)                                                                                          
  **Depression**            No                  1.00                1.00                1.00                1.00                NS                  1.00                1.00                1.00   \-
  Yes                       1.25 (1.09--1.43)   1.18 (1.02--1.37)   1.14 (1.06--1.23)   1.20 (1.07--1.33)   1.88 (1.76--2.00)   1.13 (1.05--1.21)   1.17 (1.07--1.27)                              

HRs (95% CI). White background: p\<0.05, light gray: p\<0.01, middle gray: p\<0.001, dark gray: p\<0.0001, NS: non-significant.

10.1371/journal.pone.0162386.t013

###### Summary of the numbers of predictive and predicted factors and of the total number of factors independently associated with each CVD risk factor according to the significance threshold.
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                                    Significance threshold    Number of predictive factors   Number of predicted factors   Total number of associated factors   
  --------------------------------- ------------------------- ------------------------------ ----------------------------- ------------------------------------ ---
  **Non-modifiable factors**        **Gender**                \<0.05                         0                             2                                    2
  \<0.01                            0                         2                              2                                                                  
  \<0.001                           0                         1                              1                                                                  
  \<0.0001                          0                         1                              1                                                                  
  **Age**                           \<0.05                    0                              4                             4                                    
  \<0.01                            0                         4                              4                                                                  
  \<0.001                           0                         4                              4                                                                  
  \<0.0001                          0                         3                              3                                                                  
  **Parental CVD**                  \<0.05                    0                              5                             5                                    
  \<0.01                            0                         2                              2                                                                  
  \<0.001                           0                         1                              1                                                                  
  \<0.0001                          0                         1                              1                                                                  
  **Behavioural factors**           **Alcohol consumption**   \<0.05                         1                             0                                    1
  \<0.01                            0                         0                              0                                                                  
  \<0.001                           0                         0                              0                                                                  
  \<0.0001                          0                         0                              0                                                                  
  **Smoking**                       \<0.05                    2                              7                             7                                    
  \<0.01                            1                         6                              6                                                                  
  \<0.001                           1                         5                              5                                                                  
  \<0.0001                          0                         4                              4                                                                  
  **Physical activity**             \<0.05                    6                              4                             7                                    
  \<0.01                            5                         2                              5                                                                  
  \<0.001                           3                         1                              4                                                                  
  \<0.0001                          2                         1                              2                                                                  
  **Upstream clinical factors**     **Obesity**               \<0.05                         5                             5                                    6
  \<0.01                            5                         5                              6                                                                  
  \<0.001                           3                         5                              5                                                                  
  \<0.0001                          3                         4                              5                                                                  
  **Sleep disorder**                \<0.05                    5                              3                             7                                    
  \<0.01                            5                         3                              7                                                                  
  \<0.001                           3                         2                              4                                                                  
  \<0.0001                          2                         2                              3                                                                  
  **Depression**                    \<0.05                    4                              7                             9                                    
  \<0.01                            3                         6                              8                                                                  
  \<0.001                           3                         4                              6                                                                  
  \<0.0001                          2                         1                              2                                                                  
  **Downstream clinical factors**   **Hypertension**          \<0.05                         8                             4                                    8
  \<0.01                            6                         3                              7                                                                  
  \<0.001                           6                         3                              7                                                                  
  \<0.0001                          5                         3                              6                                                                  
  **Dyslipidemia**                  \<0.05                    9                              4                             9                                    
  \<0.01                            7                         4                              8                                                                  
  \<0.001                           5                         2                              6                                                                  
  \<0.0001                          4                         2                              5                                                                  
  **Diabetes**                      \<0.05                    7                              2                             7                                    
  \<0.01                            5                         0                              5                                                                  
  \<0.001                           4                         0                              4                                                                  
  \<0.0001                          4                         0                              4                                                                  

For each factor, the number of predictive factors refers to the number of factors predicting this factor in the corresponding regression while the number of predicted factors designates the number of factors predicted by this factor in all the regressions.

Discussion {#sec010}
==========

The present study systematically reports prospective associations between the main behavioural or clinical CVD risk factors in a cohort of middle-aged volunteers free of CVD at baseline and followed over 20 years. The 12 factors retained for the analyses are all independently associated with the risk of CVD events in a dose-dependent manner for non-binary factors and in agreement with the literature \[[@pone.0162386.ref003], [@pone.0162386.ref004], [@pone.0162386.ref007], [@pone.0162386.ref008], [@pone.0162386.ref010], [@pone.0162386.ref014], [@pone.0162386.ref036]--[@pone.0162386.ref042]\]. Beside their independent associations with CVD events, our results show that these risk factors form an extensive network of relationships with each other. The most straightforward observation that can be made from the overall view of this network is that the number of factors associated with a given factor, as well as the number of factors predicting a given factor or predicted by it, are quite variable, suggesting that all the factors do not have an equivalent position within the network. A conceptual framework can be tentatively proposed in which four types of factors are identified on the basis of their nature and of the number of relationships they formed with each other (**[Fig 1](#pone.0162386.g001){ref-type="fig"}**). Non-modifiable factors (gender, age, parental history of CVD) obviously only predict and are not predicted by other factors. Behavioural factors (non-moderate drinking, smoking, physical inactivity) form very few associations with each other, they predict several clinical factors and are predicted by a small number of non-modifiable or clinical factors. Upstream clinical factors (obesity, sleep disorder, depression) form a few associations with each other, they predict many downstream clinical factors and are predicted by many non-modifiable or behavioural factors. Downstream clinical factors (hypertension, dyslipidemia, diabetes) form many associations with each other, they predict very few factors but are predicted by a large number of non-modifiable, behavioural factors or upstream clinical factors.

In theory, the extent of this network of relationships between the risk factors underlines the necessity of considering all the factors together to evaluate CVD risk. Approaches such as structural analyses should allow to determine the relative contribution of each factor to the overall CVD risk and to explore what type of relationships (additive, synergistic) exists between the different factors \[[@pone.0162386.ref021]\]. An adjacent question would be to disentangle how the contribution of each factor divides up between its independent effect and the effect mediated by the relationships with the other factors, or in other words, how the risk predicted by a given factor varied in relation to the burden of interacting factors \[[@pone.0162386.ref001]\]. However, from a practical viewpoint, it has been demonstrated that 75--90% of coronary heart disease incidence in most populations is explained by only a few key risk factors, mainly the downstream clinical factors funnelling the effects of the other factors within the network (hypertension, dyslipidemia, diabetes) \[[@pone.0162386.ref043]\]. It has also been shown that adding new factors besides the key ones to existing algorithms and scores only marginally improves risk prediction \[[@pone.0162386.ref025]\]. Thus, despite its potential theoretical interest, taking into account the interaction network between CVD risk factors will probably not add much to the identification of individuals at risk.

In contrast, integrating this network in the design and implementation of primary or secondary preventive strategies aiming to lower CVD risk, whose efficiency has remained very disappointing \[[@pone.0162386.ref026], [@pone.0162386.ref027]\], may have some utility. One reason of the lack of success of these strategies lies in the intensity of the interventions that is usually insufficient to significantly reduce exposure to the risk factors. The global view of the interaction network between these risk factors suggests another reason: not taking into account the relationships between the factors can lead to partial or contradictory interventions if the simultaneous presence of these factors is susceptible to appreciably influence the reduction of the exposure to any one of them. For example, when it is necessary to manage diabetes in obese patients who are also smokers and depressed. Generally, the relationships formed by downstream clinical factors should be given a particular attention considering that they are predicted by a large number of other factors.

The present study has several limitations. A first one concerns the very limited set of CVD risk factors that have been tested among all those which are available \[[@pone.0162386.ref044]\]. A second limitation is that the diagnosis of behaviours, clinical phenotypes and CVD outcomes could suffer from significant imprecisions as they were self-reported, even though the fact that all the risk factors predict CVD events as expected and that many associations between these factors are also in agreement with the literature is reassuring. A third limitation concerns the potential generalization of the findings that may be limited due to the specific characteristics of the present cohort. In addition to the unusual sex ratio and rather narrow age range, the selection of volunteers working in a French public company necessarily leads to a healthy cohort as shown by the low prevalence/incidence of CVD events and risk factors \[[@pone.0162386.ref045]\], a bias further accentuated by the exclusion of workers with missing values. It is therefore difficult to appreciate the applicability of the findings to other contexts until similar analyses are performed in cohorts with different characteristics. A fourth limitation concerns the interpretation of the associations identified by proportional hazard regression. Some of them such as the prediction of hypertension or diabetes by body mass index probably correspond to cause and effect relationships as demonstrated by intervention studies \[[@pone.0162386.ref046], [@pone.0162386.ref047]\]. But other associations such as those between hypertension, dyslipidemia and diabetes are less likely to be causal and would rather reflect an underlying common pathological process that develops over the long-term. This process would increase the risk of occurrence of these phenotypes at different rates, resulting in the apparent prediction of some phenotypes by those already present at baseline. Thus, the number of causal relationships between the risk factors is probably significantly less than the number of associations reported in the results. A fifth limitation is related to the potential specificities of predictive and predicted risk factors which have not been assessed in this study. Although a given risk factor is a well-defined behavioural or clinical phenotype, it presents some differences when acting as predictive or predicted factor. As predictive factor, it reflects the prevalence of the phenotype at the beginning of the follow-up while as predicted factor it reflects the incidence of the phenotype during the follow-up. In the second case, it is the frequency of appearance of the phenotype over time while in the first case it is the result of the past incidence of the phenotype accumulated over some period of time during which the volunteers were exposed to the phenotype before the beginning of the follow-up. Generally, the risk associated with a given predicted/incident factor will not be identical to that associated with the corresponding predictive/prevalent factor because this is likely to depend on the duration of the exposure to the factor.

Conclusions {#sec011}
===========

The present study assessed in a single cohort all prospective associations between the main behavioural and clinical CVD risk factors. It provides a global view of the extensive network of relationships formed by these factors in parallel with their independent associations with CVD risk, highlighting the inadequacy of considering a factor or even a few without taking into account the interactions with the other factors. The extent of this network is probably underestimated and not sufficiently taken into account in the preventive strategies aiming to lower CVD risk, explaining perhaps in part their lack of efficiency.
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